Natural History of Non-operative Management in Asymptomatic Patients with 70%-80% Internal Carotid Artery Stenosis by Duplex Criteria.


Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 08 12 2019
revised: 04 05 2020
accepted: 27 05 2020
pubmed: 15 7 2020
medline: 21 10 2020
entrez: 15 7 2020
Statut: ppublish

Résumé

Treatment of asymptomatic internal carotid artery (ICA) stenosis, particularly for moderate to severe (70%-80%) disease, is controversial. The goal was to assess the clinical course of patients with moderate to severe carotid stenosis. A single institution retrospective analysis of patients with asymptomatic ICA stenosis identified on duplex ultrasound as moderate to severe (70%-80%) from 2003 to 2018 were analysed. Duplex criteria for 70%-80% stenosis was a systolic velocity of ≥325 cm/s or an ICA:common carotid artery ratio of ≥4, and an end diastolic velocity of <140 cm/s. Asymptomatic status was defined as no stroke/transient ischaemic attack (TIA) within six months of index duplex. Primary outcomes were progression of stenosis to >80%, ipsilateral stroke/TIA without documented progression, and death. In total, 206 carotid arteries were identified in 182 patients meeting the inclusion criteria. Mean patient age was 71.5 years, 57.7% were male, and 67% were white. There were 19 stenoses removed from analysis except for survival analysis as they initially underwent carotid endarterectomy or carotid artery stent based on surgeon/patient preference. Documented progression occurred in 24.1% of stenoses. There were 5.3% of stenoses associated with an ipsilateral stroke/TIA without documented progression, which occurred at a mean of 26.4 months. Kaplan-Meier analysis demonstrated a 60.3% five year freedom from stenosis progression, 92.5% five year freedom from stroke/TIA without documented progression, and 83.7% five year survival. Risk factors associated with stroke/TIA without documented progression at five years were atrial fibrillation (hazard ratio [HR] 14.87, 95% confidence interval [CI] 2.72-81.16; p = .002) and clopidogrel use at index duplex (HR 6.19, 95% CI 1.33-28.83; p = .020). Risk factors associated with death at five years were end stage renal disease (HR 9.67, 95% CI 2.05-45.6; p = .004), atrial fibrillation (HR 7.55, 95% CI 2.48-23; p < .001), prior head/neck radiation (HR 6.37, 95% CI 1.39-29.31; p = .017), non-obese patients (HR 5.49, 95% CI 1.52-20; p = .009), and non-aspirin use at index duplex (HR 3.05, 95% CI 1.12-8.33; p = .030). Patients with asymptomatic moderate to severe carotid stenosis had a low rate of stroke/TIA without documented progression. However, there was a high rate of stenosis progression reinforcing the need to follow these patients closely.

Identifiants

pubmed: 32660806
pii: S1078-5884(20)30512-8
doi: 10.1016/j.ejvs.2020.05.039
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

339-346

Informations de copyright

Copyright © 2020 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Auteurs

Thomas W Cheng (TW)

Division of Vascular and Endovascular Surgery, Boston Medical Centre, Boston University School of Medicine, Boston, MA, USA.

Keyona E Pointer (KE)

Division of Vascular and Endovascular Surgery, Boston Medical Centre, Boston University School of Medicine, Boston, MA, USA.

Mallika Gopal (M)

Division of Vascular and Endovascular Surgery, Boston Medical Centre, Boston University School of Medicine, Boston, MA, USA.

Alik Farber (A)

Division of Vascular and Endovascular Surgery, Boston Medical Centre, Boston University School of Medicine, Boston, MA, USA.

Douglas W Jones (DW)

Division of Vascular and Endovascular Surgery, Boston Medical Centre, Boston University School of Medicine, Boston, MA, USA.

Robert T Eberhardt (RT)

Division of Cardiovascular Medicine, Boston Medical Centre, Boston University School of Medicine, Boston, MA, USA.

Jeffrey A Kalish (JA)

Division of Vascular and Endovascular Surgery, Boston Medical Centre, Boston University School of Medicine, Boston, MA, USA.

Mohammad H Eslami (MH)

Division of Vascular Surgery, University of Pittsburgh Medical Centre, Pittsburgh, PA, USA.

Denis Rybin (D)

Department of Biostatistics, Boston University, School of Public Health, Boston, MA, USA.

Jeffrey J Siracuse (JJ)

Division of Vascular and Endovascular Surgery, Boston Medical Centre, Boston University School of Medicine, Boston, MA, USA. Electronic address: Jeffrey.Siracuse@bmc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH